vs
Orthofix Medical Inc.（OFIX）与Root, Inc.（ROOT）财务数据对比。点击上方公司名可切换其他公司
Root, Inc.的季度营收约是Orthofix Medical Inc.的1.8倍（$397.0M vs $219.9M），Root, Inc.同比增速更快（21.5% vs 2.0%），过去两年Root, Inc.的营收复合增速更高（24.8% vs 8.0%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
Root Inc.旗下的Root保险公司是一家专注于汽车保险的线上保险公司，业务主要运营于美国地区，依托数字化技术为美国车主提供便捷的线上汽车保险服务。
OFIX vs ROOT — 直观对比
营收规模更大
ROOT
是对方的1.8倍
$219.9M
营收增速更快
ROOT
高出19.5%
2.0%
两年增速更快
ROOT
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $397.0M |
| 净利润 | $-2.2M | — |
| 毛利率 | 71.1% | — |
| 营业利润率 | 0.2% | 2.6% |
| 净利率 | -1.0% | — |
| 营收同比 | 2.0% | 21.5% |
| 净利润同比 | 92.4% | — |
| 每股收益（稀释后） | $-0.05 | $0.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXROOT
| Q4 25 | $219.9M | $397.0M | ||
| Q3 25 | $205.6M | $387.8M | ||
| Q2 25 | $203.1M | $382.9M | ||
| Q1 25 | $193.6M | $349.4M | ||
| Q4 24 | $215.7M | $326.7M | ||
| Q3 24 | $196.6M | $305.7M | ||
| Q2 24 | $198.6M | $289.2M | ||
| Q1 24 | $188.6M | $254.9M |
净利润OFIXROOT
| Q4 25 | $-2.2M | — | ||
| Q3 25 | $-22.8M | $-5.4M | ||
| Q2 25 | $-14.1M | $22.0M | ||
| Q1 25 | $-53.1M | $18.4M | ||
| Q4 24 | $-29.1M | — | ||
| Q3 24 | $-27.4M | $22.8M | ||
| Q2 24 | $-33.4M | $-7.8M | ||
| Q1 24 | $-36.0M | $-6.2M |
毛利率OFIXROOT
| Q4 25 | 71.1% | — | ||
| Q3 25 | 72.2% | — | ||
| Q2 25 | 68.7% | — | ||
| Q1 25 | 62.8% | — | ||
| Q4 24 | 69.0% | — | ||
| Q3 24 | 68.7% | — | ||
| Q2 24 | 67.8% | — | ||
| Q1 24 | 67.5% | — |
营业利润率OFIXROOT
| Q4 25 | 0.2% | 2.6% | ||
| Q3 25 | -8.3% | 0.1% | ||
| Q2 25 | -7.9% | 7.1% | ||
| Q1 25 | -25.2% | 6.8% | ||
| Q4 24 | -5.3% | 10.7% | ||
| Q3 24 | -9.6% | 11.3% | ||
| Q2 24 | -12.5% | 1.3% | ||
| Q1 24 | -15.6% | 2.1% |
净利率OFIXROOT
| Q4 25 | -1.0% | — | ||
| Q3 25 | -11.1% | -1.4% | ||
| Q2 25 | -6.9% | 5.7% | ||
| Q1 25 | -27.4% | 5.3% | ||
| Q4 24 | -13.5% | — | ||
| Q3 24 | -13.9% | 7.5% | ||
| Q2 24 | -16.8% | -2.7% | ||
| Q1 24 | -19.1% | -2.4% |
每股收益（稀释后）OFIXROOT
| Q4 25 | $-0.05 | $0.35 | ||
| Q3 25 | $-0.57 | $-0.35 | ||
| Q2 25 | $-0.36 | $1.29 | ||
| Q1 25 | $-1.35 | $1.07 | ||
| Q4 24 | $-0.76 | $1.42 | ||
| Q3 24 | $-0.71 | $1.35 | ||
| Q2 24 | $-0.88 | $-0.52 | ||
| Q1 24 | $-0.95 | $-0.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $669.3M |
| 总债务越低越好 | — | $200.3M |
| 股东权益账面价值 | $450.0M | $284.3M |
| 总资产 | $850.6M | $1.7B |
| 负债/权益比越低杠杆越低 | — | 0.70× |
8季度趋势，按日历期对齐
现金及短期投资OFIXROOT
| Q4 25 | $82.0M | $669.3M | ||
| Q3 25 | $62.9M | $653.3M | ||
| Q2 25 | $65.6M | $641.4M | ||
| Q1 25 | $58.0M | $609.4M | ||
| Q4 24 | $83.2M | $599.3M | ||
| Q3 24 | $30.1M | $674.8M | ||
| Q2 24 | $26.4M | $667.2M | ||
| Q1 24 | $27.0M | $640.5M |
总债务OFIXROOT
| Q4 25 | — | $200.3M | ||
| Q3 25 | $157.2M | $200.4M | ||
| Q2 25 | $157.0M | $200.1M | ||
| Q1 25 | $156.9M | $200.0M | ||
| Q4 24 | $157.0M | $200.1M | ||
| Q3 24 | $118.5M | $300.9M | ||
| Q2 24 | $118.0M | $300.1M | ||
| Q1 24 | $118.2M | $299.3M |
股东权益OFIXROOT
| Q4 25 | $450.0M | $284.3M | ||
| Q3 25 | $442.5M | $265.0M | ||
| Q2 25 | $458.3M | $244.5M | ||
| Q1 25 | $458.3M | $228.7M | ||
| Q4 24 | $503.1M | $203.7M | ||
| Q3 24 | $525.9M | $181.9M | ||
| Q2 24 | $546.0M | $151.3M | ||
| Q1 24 | $570.3M | $165.7M |
总资产OFIXROOT
| Q4 25 | $850.6M | $1.7B | ||
| Q3 25 | $832.6M | $1.6B | ||
| Q2 25 | $837.2M | $1.6B | ||
| Q1 25 | $823.1M | $1.6B | ||
| Q4 24 | $893.3M | $1.5B | ||
| Q3 24 | $867.9M | $1.6B | ||
| Q2 24 | $882.0M | $1.5B | ||
| Q1 24 | $906.0M | $1.4B |
负债/权益比OFIXROOT
| Q4 25 | — | 0.70× | ||
| Q3 25 | 0.36× | 0.76× | ||
| Q2 25 | 0.34× | 0.82× | ||
| Q1 25 | 0.34× | 0.87× | ||
| Q4 24 | 0.31× | 0.98× | ||
| Q3 24 | 0.23× | 1.65× | ||
| Q2 24 | 0.22× | 1.98× | ||
| Q1 24 | 0.21× | 1.81× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $206.5M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | — |
| 自由现金流率自由现金流/营收 | 7.6% | — |
| 资本支出强度资本支出/营收 | 4.9% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.3M | — |
8季度趋势，按日历期对齐
经营现金流OFIXROOT
| Q4 25 | $27.7M | $206.5M | ||
| Q3 25 | $12.4M | $57.6M | ||
| Q2 25 | $11.6M | $52.0M | ||
| Q1 25 | $-18.4M | $26.8M | ||
| Q4 24 | $23.7M | $195.7M | ||
| Q3 24 | $11.7M | $49.4M | ||
| Q2 24 | $9.0M | $62.6M | ||
| Q1 24 | $-18.6M | $14.5M |
自由现金流OFIXROOT
| Q4 25 | $16.8M | — | ||
| Q3 25 | $2.5M | — | ||
| Q2 25 | $4.5M | — | ||
| Q1 25 | $-25.1M | — | ||
| Q4 24 | $15.2M | $195.3M | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $-360.0K | $62.4M | ||
| Q1 24 | $-29.1M | $14.3M |
自由现金流率OFIXROOT
| Q4 25 | 7.6% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 2.2% | — | ||
| Q1 25 | -13.0% | — | ||
| Q4 24 | 7.0% | 59.8% | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | -0.2% | 21.6% | ||
| Q1 24 | -15.4% | 5.6% |
资本支出强度OFIXROOT
| Q4 25 | 4.9% | 0.0% | ||
| Q3 25 | 4.8% | 0.0% | ||
| Q2 25 | 3.5% | 0.0% | ||
| Q1 25 | 3.5% | 0.0% | ||
| Q4 24 | 4.0% | 0.1% | ||
| Q3 24 | 2.7% | 0.0% | ||
| Q2 24 | 4.7% | 0.1% | ||
| Q1 24 | 5.6% | 0.1% |
现金转化率OFIXROOT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.36× | ||
| Q1 25 | — | 1.46× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.17× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
ROOT
暂无分部数据
